Pathogenesis of secondary hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 3, 1996, Pages 130-135

  Slatopolsky, E ^a   Delmez, J A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcitriol; Calcium; Phosphorus; Secondary hyperparathyroidism; Uraemia

Indexed keywords

CALCITRIOL; OXYGENASE; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

CELL HYPERPLASIA; CONFERENCE PAPER; HEMODIALYSIS; KIDNEY FAILURE; PARATHYROID CELL; PARATHYROID HORMONE RELEASE; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; VITAMIN D METABOLISM;

EID: 0029736822     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp3.130     Document Type: Conference Paper

References (32)

1. Okazaki T, Zajac JD, Igarashi T, Ogata E, Kronenberg HM. Negative regulatory elements in the human parathyroid hormone gene. J Biol Chem 1991; 266: 21903-21910
2. 3. Proc Natl Acad Sci USA 1992; 89: 8097-8101
3. 3 in the parathyroid glands of patients with renal failure. New Engl J Med 1987; 316: 1573-1577
4. 3 receptors in experimental uremia. Kidney Int 1987; 32: 350-353
5. 3 receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 1989; 35: 19-23
6. 3 in the parathyroid in vivo. J Clin Invest 1990; 86: 1968-1975
7. Kremer R, Bolivar I, Goltzman D, Hendy GN. Influence of calcium and 1,25-dihydroxycholecalficerol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989; 125: 935-941
8. 3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1989; 35: 1049-1056
9. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
10. Gittes FR, Radde IC. Experimental model for hyperparathyroidism: effect of excessive numbers of transplanted isologous parathyroid glands. J Urol 1966; 95: 595-603
11. Mayer GP, Habener JF, Potts JT Jr. Parathyroid hormone secretion in vivo: Demonstration of a calcium-independent, non-suppressible component of secretion. J Clin Invest 1976; 57: 678-683
12. Brown EM, Brennan MF, Hurwitz S, Windeck R, Marx S, Spiegel AM, Koehler JO, Gardner DG, Aurbach GD. Dispersed cells prepared from human parathyroid glands: Distinct calcium sensitivity of adenomas vs. primary hyperplasia. J Clin Endocrinol Metab 1978; 46: 267-275
13. Brown EM, Wilkson RE, Eastman RC, Pallotta J, Marynick SP. Abnormal regulation of parathyroid hormone release of calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 1982; 54: 172-179
14. Bellorin-Font E, Martin KJ, Freitag JJ, Anderson C, Sicard G, Slatopolsky E, Klahr S. Altered adenylate cyclase kinetics in hyperfunctioning human parathyroid glands. Comparison with normal human and bovine parathyroid tissue. J Clin Endocrinol Metab 1981; 52: 499-507
15. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: a role for increased sensitivity to calcium. J Clin Invest 1989; 83: 1349-1355
16. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 1989; 36: 1093-1098
17. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143
18. 3 pulse therapy. Nephron 1989; 51: 130-131
19. 3 in experimental renal hyperparathyroidism. Kidney Int 1993; 44: 1259-1265
20. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580
21. 2+-sensing receptor gene cause familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297-1303
22. Kifor O, Moore FD, Wang P, Goldstein M, Vassileu P, Kifor I, Hebert S, Brown EM. Reduced Ca-Receptor expression in parathyroid adenomas and uremic hyperparathyroidism [abstract]. J Bone Miner Res 10 (suppl 1): M530
23. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drucke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J clin Invest 1995; 95: 2047-2053
24. Tanaka Y, DeLuca HF. The control of 25-dihydroxyvitamin D metabolism by inorganic phosphorus. Arch Biochem Biophys 1973; 154: 566-574
25. Portale AA, Booth BE, Halloran BP, Morris RC Jr. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1987; 73: 1580-1589
26. Lopez-Hilker S, Dusso A, Rapp N, Martin K, Slatopolsky E. Phosphorus restriction reverses secondary hyperparathyroidism in chronic renal failure independent of changes in calcium and 1,25 dihydroxycholecacliferol. Am J Physiol 1990; 259: F432-F437
27. Lucas PA, Brown RC, Woodhead JS, Coles GA. 1,25-Dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction. Clin Nephrol 1986; 25: 7-10
28. Schaefer K, Erley CM, von Herrath D, Stein G. Calcium salts of ketoacids as a new treatment strategy for uremic hyperphosphatemia. Kidney Int 1989; 36: S136-S139
29. Tessitore NA, Venturi A, Adami C, Roncari C, Rugiu A, Corgnati E, Bonucci E, Maschio G. Relationship between plasma vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. Miner Electrolyte Metab 1987; 13: 38-44
30. Dabbagh S, Chesney R, Gusowski N, Mathews MC, Padilla M, Theissen M, Slatopolsky E. Amino aciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP. Miner Electrolyte Metab 1989; 15: 221-232
31. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald P, Brown A. Phosphate restriction prevents parathyroid cell growth in uremic rats and high phosphate directly stimulates PTH secretion in tissue culture [abstract]. JASN 6: P1413
32. Slatopolsky E, Coburn JW. In Avioli, Krane, eds. Metabolic Bone Disease, 2nd edn. Orlando, FL: Grune & Stratton, 1985